Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
| FLUX | INFLUENZA (SEASONAL) (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | — |
Chills; fever; unable to get out of bed or move; This is a spontaneous report received from a Consumer or other non HCP. A 48-year-old male patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), on 30Sep2025 at 10:30 as dose 1, single (Batch/Lot number: unknown) at the age of 48 years for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 30Sep2025 as dose number unknown, single for immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: SYNTHROID; CRESTOR taken for lipid management. The following information was reported: CHILLS (non-serious) with onset 01Oct2025, outcome "recovered"; PYREXIA (non-serious) with onset 01Oct2025, outcome "recovered", described as "fever"; MOBILITY DECREASED (non-serious) with onset 01Oct2025, outcome "recovered", described as "unable to get out of bed or move". Therapeutic measures were taken as a result of chills, pyrexia, mobility decreased. Additional information: Patient did not receive any other vaccines within 4 weeks PRIOR to the vaccine(s) for which you are reporting, the patient received other medications within 2 weeks of the event starting. Patient received treatment for the adverse event with Advil. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
SYNTHROID; CRESTOR